Warning: Missing argument 1 for get_pagelink_by_slug(), called in /export/sd09/www/jp/r/e/gmoserver/7/3/sd0131973/jpcnma.or.jp/wp-content/themes/jpcnma/header.php on line 111 and defined in /export/sd09/www/jp/r/e/gmoserver/7/3/sd0131973/jpcnma.or.jp/wp-content/themes/jpcnma/admin/functions-theme-basic.php on line 98

機関誌『日中医学』

特集:日中における消化器癌治療の最前線

巻頭言 「日中における消化器癌治療の最前線」に寄せて

杏林大学医学部付属病院消化器・一般外科 教授
正木忠彦

中国における大腸癌治療の最前線

浙江大学医学院附属第一病院消化器内科
虞朝輝※1、馬 丹
1.主任

Advances in clinical treatment of colorectal cancer
 

【Abstract】
Colorectal cancer is one of the most common digestive tract tumors, and its morbidity and mortality have been rising dramatically in recent years. At present, the main treatment methods for colorectal cancer include surgery, radiotherapy and chemotherapy, targeted therapy, immunotherapy, and traditional Chinese medicine. In particular, targeted drugs and immunotherapy drugs have achieved good results in clinical treatment, which can significantly improve the prognosis, prolong the survival period, and improve the quality of life of patients.

【Key words】
Colorectal cancer, Clinical treatment, Advances

中国における肝胆膵悪性腫瘍治療の最前線

杭州医学院
浙江省人民病院浙江省腫瘍分子診断・個別化治療研究重点実験室
(杭州医学院附属人民病院)
黄東勝※1、梁 磊、楊 田
※1.教授(責任著者)

浙江省人民病院肝胆膵外科· 低侵襲外科
(杭州医学院附属人民病院)
梁 磊、楊 田、張成武

The progress of treatments for hepatobiliary and pancreatic cancers in China
 

【Abstract】
Primary hepatobiliary and pancreatic tumors are common clinical malignancies, with an increasing incidence and poor prognosis. In order to improve the clinical diagnosis, treatment and research level of hepatobiliary and pancreatic tumors, promote related translational and clinical research, and strengthen academic exchanges and scientific and technological cooperation, we hereby describe the progress of the treatment for hepatobiliary and pancreatic cancer in China.

【Key words】
hepatocellular carcinoma, biliary tract cancer, pancreatic cancer, treatment, prognosis

日本における大腸癌治療の最前線

日本赤十字社医療センター大腸肛門外科
佐々木愼※1、赤井隆司、金子 学、 豊島 明※2
※1.部長 ※2.副部長

Forefront of colorectal cancer treatment in Japan 
 

【Abstract】
Although JCOG0404 couldn’t confirm non-inferiority of laparoscopic surgery for colon cancer to open, it could be interpreted it is acceptable. Minimally invasive surgery including laparoscopic, robot-assisted, and TaTME will probably continue to increase. Furthermore, the treatment outcome for rectal cancer will improve by setting of appropriate adaptation criteria of lateral lymph node dissection and preoperative chemoradiotherapy, and by evaluation of blood flow at the anastomotic site using ICG fluorescence imaging.

【Key words】
laparoscopic colorectal surgery, robotic-assisted laparoscopic surgery, preoperative chemoradiotherapy, lateral lymph node dissection, indocyanine green fluorescence imaging

日本における肝癌、膵癌治療の最前線

杏林大学医学部付属病院肝胆膵外科
阪本良弘※1、百瀬博一、松木亮太、小暮正晴、鈴木 裕、森 俊幸
※1.診療科長・教授

The front lines of the treatments for liver and pancreatic cancer in Japan
 

【Abstract】
In the recent 20 years, survival rate of patients with unresectable hepatocellular carcinoma has improved owing to the development of owing to the development of chemotherapy using molecular targeted drugs and immune checkpoint inhibitor. Multidisciplinary treatment for resectable/borderline resectable/unresectable pancreatic cancer has also progressed owing to the combination of aggressive surgical resection and advance of systemic chemotherapy.

【Key words】
Hepatocellular carcinoma, molecular targeted drug, immune checkpoint inhibitor, pancreatic cancer, adjuvant chemotherapy

 

架け橋 
      
      

「第7次世界中西医結合大会」で発表する機会に恵まれて
近藤クリニック 院長
近藤高志

インタビュー
在日中国人研究者を訪ねて

「幹細胞」の万能性を活かし、あらゆる疾病の病態解明と効果的な治療方法の開発を目指す
長崎大学原爆後障害医療研究所 幹細胞生物学分野(原研幹細胞)教授
李 桃生

笹川生 in China 
     
     

笹川医学奨学金が開いた新たな人生の扉
上海市東方病院(同済大学附属東方病院)胃腸外科 主治医師
張 順

あとがき 広報委員会委員  須並英二
機関誌『日中医学』投稿原稿募集の
お知らせ